Quantum computational analysis for drug resistance of HIV‐1 reverse transcriptase to nevirapine through point mutations

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Proteins: Structure, Function, and Bioinformatics

• Publication date

  2005-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/prot.20578PMID 16114038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FULL AB INITIO COMPUTATION OF PROTEIN-WATER INTERACTION ENERGIES

  2004cited by this paper
• Fully quantum mechanical energy optimization for protein–ligand structure

  2004cited by this paper
• Quantum mechanical map for protein-ligand binding with application to beta-trypsin/benzamidine complex.

  2004cited by this paper
• Fractionation of peptide with disulfide bond for quantum mechanical calculation of interaction energy with molecules.

  2004cited by this paper
• Molecular fractionation with conjugate caps for full quantum mechanical calculation of protein-molecule interaction energy

  2003influential reference
• Molecular caps for full quantum mechanical computation of peptide–water interaction energy

  2003cited by this paper
• New Advance in Computational Chemistry:  Full Quantum Mechanical ab Initio Computation of Streptavidin-Biotin Interaction Energy.

  2003cited by this paper
• Theoretical investigation on nevirapine and HIV-1 reverse transcriptase binding site interaction, based on ONIOM method

  2003influential reference
• Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations.

  2002influential reference
• New developments in anti-HIV chemotherapy.

  2002cited by this paper
• Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors.

  2001cited by this paper
• Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA.

  2001cited by this paper
• Estimation of binding affinities for HEPT and nevirapine analogues with HIV-1 reverse transcriptase via Monte Carlo simulations.

  2001influential reference
• The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages.

  2001cited by this paper
• New developments in anti-HIV chemotherapy

  2001influential reference
• Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase.

  2000cited by this paper
• The HIV‐1 Reverse Transcription (RT) Process as Target for RT Inhibitors

  2000cited by this paper
• Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.

  2000cited by this paper
• Fragment molecular orbital method: application to polypeptides

  2000cited by this paper
• Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  1999cited by this paper
• Mutations in Retroviral Genes Associated with Drug Resistance

  1996cited by this paper
• Non‐nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV‐1) infections: Strategies to overcome drug resistance development

  1996cited by this paper
• L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

  1995influential reference
• AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules

  1995cited by this paper
• High resolution structures of HIV-1 RT from four RT–inhibitor complexes

  1995cited by this paper
• IMOMM: A new integrated ab initio + molecular mechanics geometry optimization scheme of equilibrium structures and transition states

  1995cited by this paper
• The retroviral enzymes.

  1994cited by this paper
• Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

  1994cited by this paper
• Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

  1993cited by this paper
• Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.

  1992influential reference
• Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

  1992cited by this paper
• Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.

  1991cited by this paper
• Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.

  1991cited by this paper
• Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5'-triphosphates of carbovir, 3'-azido-3'-deoxythymidine, 2',3'-dideoxyguanosine and 3'-deoxythymidine. A novel RNA template for the evaluation of antiretrovir

  1991cited by this paper
• Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.

  1991cited by this paper
• Molecular targets for AIDS therapy.

  1990cited by this paper

• Quantum Approximate Optimization Algorithm for Spatiotemporal Forecasting of HIV Clusters

  2025cites this paper
• Fragmentation-Based Decomposition of a Metalloenzyme-Substrate Interaction: A Case Study for a Lytic Polysaccharide Monooxygenase.

  2022cites this paper
• Towards the quantum-enabled technologies for development of drugs or delivery systems.

  2020cites this paper
• Integrative approaches in HIV‐1 non‐nucleoside reverse transcriptase inhibitor design

  2018cites this paper
• MFCC‐Based Fragmentation Methods for Biomolecules

  2017cites this paper
• Theoretical studies of energetics and binding isotope effects of binding a triazole-based inhibitor to HIV-1 reverse transcriptase.

  2016cites this paper
• Predicting the relative binding affinity of mineralocorticoid receptor antagonists by density functional methods

  2015cites this paper
• Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors

  2015cites this paper
• Binding isotope effects as a tool for distinguishing hydrophobic and hydrophilic binding sites of HIV-1 RT.

  2015cites this paper
• Calculation of protein–ligand binding affinities based on a fragment quantum mechanical method

  2015cites this paper
• Energy-Based Molecular Fragmentation Methods.

  2015cites this paper
• Protein's native structure is dynamically stabilized by electronic polarization

  2014cites this paper
• Density Functional Theory Calculations of Enzyme–Inhibitor Interactions in Medicinal Chemistry and Drug Design

  2014cites this paper
• The quantum biophysics of the isoniazid adduct NADH binding to its InhA reductase target

  2014cites this paper
• Effects of the protonation state in the interaction of an HIV-1 reverse transcriptase (RT) amino acid, Lys101, and a non nucleoside RT inhibitor, GW420867X

  2014cites this paper
• Novel theoretically designed HIV-1 non-nucleoside reverse transcriptase inhibitors derived from nevirapine

  2014cites this paper
• Fragment quantum mechanical calculation of proteins and its applications.

  2014cites this paper
• Quantum chemical study on molecular‐level affinity of DJ‐1 binding compounds

  2013cites this paper
• An improved fragment-based quantum mechanical method for calculation of electrostatic solvation energy of proteins.

  2013cites this paper
• Fully ab initio protein‐ligand interaction energies with dispersion corrected density functional theory

  2012cites this paper
• Fragmentation methods: a route to accurate calculations on large systems.

  2012cites this paper
• Inactivation of ovine cyclooxygenase-1 by bromoaspirin and aspirin: a quantum chemistry description.

  2012cites this paper
• Theoretical studies of HIV-1 reverse transcriptase inhibition.

  2012cites this paper
• Dynamical stability and assembly cooperativity of β-sheet amyloid oligomers--effect of polarization.

  2012cites this paper
• Speed and accuracy: Having your cake and eating it too

  2012cites this paper
• Multiple drugs and multiple targets: An analysis of the electrostatic determinants of binding between non‐nucleoside HIV‐1 reverse transcriptase inhibitors and variants of HIV‐1 RT

  2012cites this paper
• Quantum Mechanics in Structure‐Based Ligand Design

  2012cites this paper
• Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method

  2011cites this paper
• Key interactions of the mutant HIV-1 reverse transcriptase/efavirenz: an evidence obtained from ONIOM method

  2011cites this paper
• Developing the Polarizable Protein Force Field : Focus on Amino Acid Residues

  2011cites this paper
• Effect of polarization on the stability of a helix dimer

  2011cites this paper
• Systematic investigation on the binding of GW420867X as HIV-1 reverse transcriptase inhibitor

  2011cites this paper
• Computational alanine scanning with linear scaling semiempirical quantum mechanical methods

  2010cites this paper
• Ligand Affinities Estimated by Quantum Chemical Calculations.

  2010cites this paper
• Modelling the binding of HIV-reverse transcriptase and nevirapine: an assessment of quantum mechanical and force field approaches and predictions of the effect of mutations on binding.

  2010cites this paper
• COMPUTATIONAL DESIGN OF NORBORNANE-BASED HIV-1 PROTEASE INHIBITORS

  2010cites this paper
• Estimates of ligand-binding affinities supported by quantum mechanical methods

  2010cites this paper
• Theoretical study on the HIV-1 integrase-5CITEP complex based on polarized force fields

  2010cites this paper
• Bridge water mediates nevirapine binding to wild type and Y181C HIV-1 reverse transcriptase--evidence from molecular dynamics simulations and MM-PBSA calculations.

  2009cites this paper
• Systematic fragmentation method and the effective fragment potential: an efficient method for capturing molecular energies.

  2009cites this paper
• Review of multicomponent molecular orbital method for direct treatment of nuclear quantum effect

  2009cites this paper
• COMPUTATIONAL STUDY FOR BINDING OF OSCILLARIN TO HUMAN α-THROMBIN

  2009cites this paper
• Intra-protein hydrogen bonding is dynamically stabilized by electronic polarization.

  2009cites this paper
• Accurate methods for large molecular systems.

  2009cites this paper
• Evaluation of methods to cap molecular fragments in calculating energies of interaction in avian pancreatic polypeptide.

  2008cites this paper
• Quantum mechanical studies of residue-specific hydrophobic interactions in p53-MDM2 binding.

  2008cites this paper
• Quantum and molecular dynamics study for binding of macrocyclic inhibitors to human alpha-thrombin.

  2007cites this paper
• Quantum and Molecular Dynamics Study for Binding of Macrocyclic Inhibitors to Human α-Thrombin

  2007cites this paper
• Extending the power of quantum chemistry to large systems with the fragment molecular orbital method.

  2007cites this paper
• Quantum study of HIV-1 protease-bridge water interaction.

  2007cites this paper
• Vibrational spectra and quantum mechanical calculations of antiretroviral drugs: Nevirapine

  2007cites this paper
• The role of quantum mechanics in structure-based drug design.

  2007cites this paper
• The importance of bio-computational tools for predicting HIV drug resistance.

  2007cites this paper
• Target-related applications of first principles quantum chemical methods in drug design.

  2006cites this paper
• Quantum mechanics in structure-based drug design.

  2006cites this paper
• Towards a Full Dimensional Exact Quantum Calculation of the Li + HF Reactive Cross Section

  2004cites this paper